Transportability of Overall Survival Estimates From US to Canadian Patients With Advanced Non–Small Cell Lung Cancer With Implications for Regulatory and Health Technology Assessment

External Control Arms in Oncology: Current Use and Future Directions

(2022) P.S. Mishra-Kalyani et al.   ANNALS OF ONCOLOGY

A Review of Generalizability and Transportability

(2022) Irina Degtiar et al.   Annual Review of Statistics and Its Application

Immunotherapy for Advanced Non–Small Cell Lung Cancer: A Decade of Progress

(2021) Misty Dawn Shields et al.   American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting

The rapidly evolving landscape of novel targeted therapies in advanced non-small cell lung cancer

(2021) Barbara Melosky et al.   LUNG CANCER

Comparative Effectiveness of Atezolizumab, Nivolumab, and Docetaxel in Patients With Previously Treated Non–Small Cell Lung Cancer

(2021) Sreeram Ramagopalan et al.   JAMA Network Open

Atezolizumab Versus Docetaxel in Pretreated Patients With NSCLC: Final Results From the Randomized Phase 2 POPLAR and Phase 3 OAK Clinical Trials

(2020) Julien Mazieres et al.   Journal of Thoracic Oncology

Avoidable flaws in observational analyses: an application to statins and cancer

(2019) Barbra A. Dickerman et al.   NATURE MEDICINE

Real‐World Outcomes of Patients with Metastatic Non‐Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval

(2018) Sean Khozin et al.   ONCOLOGIST

Generalizability of findings from randomized controlled trials is limited in the leading general medical journals

(2018) Antti Malmivaara   JOURNAL OF CLINICAL EPIDEMIOLOGY

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial

(2017) Achim Rittmeyer et al.   LANCET

Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available: Table 1.

(2016) Miguel A. Hernán et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Real-World Evidence — What Is It and What Can It Tell Us?

(2016) Rachel E. Sherman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

(2015) Hossein Borghaei et al.   NEW ENGLAND JOURNAL OF MEDICINE

Missing data in clinical trials: from clinical assumptions to statistical analysis using pattern mixture models

(2013) Bohdana Ratitch et al.   PHARMACEUTICAL STATISTICS

Implementation of G-Computation on a Simulated Data Set: Demonstration of a Causal Inference Technique

(2011) Jonathan M. Snowden et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY